Skip to main content

Month: January 2022

OTC Markets Group Welcomes Numinus Wellness Inc. to OTCQX

NEW YORK, Jan. 27, 2022 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for over 11,000 U.S. and global securities, today announced Numinus Wellness Inc. (TSX: NUMI; OTCQX: NUMIF), an integrated mental health company, has qualified to trade on the OTCQX® Best Market. Numinus Wellness Inc. upgraded to OTCQX from the Pink® market. Numinus Wellness Inc. begins trading today on OTCQX under the symbol “NUMIF.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com. Upgrading to the OTCQX Market is an important step for companies seeking to provide transparent trading for their U.S. investors. For companies listed on a qualified international exchange, streamlined market standards enable them to utilize their home market reporting...

Continue reading

Chicago Atlantic Real Estate Finance Funds Senior Secured Credit Facility to Sanctuary Medicinals

CHICAGO, Jan. 27, 2022 (GLOBE NEWSWIRE) — Chicago Atlantic Real Estate Finance, Inc. (NASDAQ: REFI) (“Chicago Atlantic” or the “Company”), a commercial real estate finance company, announced today it funded $10 million as the initial advance of a new $25 million senior secured credit facility to Sanctuary Medicinals LLC (“Sanctuary”) to support their retail and cultivation expansion in Florida. Headquartered in Apopka, Florida, Sanctuary operates a premier cultivation and processing facility with 5 operational dispensaries and plans to open more than 18 additional locations in Florida during 2022. “Sanctuary is a best-in-class operator who has proven their ability to obtain highly coveted licenses and build preeminent retail and cultivation assets at incredible speed,” said Tony Cappell, Chief Executive...

Continue reading

Troilus Gold: 2021 Year-In-Review & Outlook for 2022; an Open Letter to Shareholders From the CEO

TORONTO, Jan. 27, 2022 (GLOBE NEWSWIRE) — Troilus Gold Corp. (“Troilus” or the “Company”, TSX: TLG; OTCQX: CHXMF) today releases an open letter to shareholders from the Company’s President and Chief Executive Officer, Justin Reid. While a copy of the letter is presented in this press release, the original document can be found on our website HERE. Dear Shareholders, 2021 was an intensive year of work by the Troilus team as it continued to solidify the foundations and advance our mining project, which we believe has the potential to be a cornerstone Canadian mine for decades to come. On all fronts, our project and our team have never been in a stronger position. First and foremost, we had great success with the drill bit and in the field, while our expanded engineering team has been busy calculating trade-offs and analyzing options...

Continue reading

ConnectOne Bancorp, Inc. Reports Fourth Quarter and Record Full-Year 2021 Results

ENGLEWOOD CLIFFS, N.J., Jan. 27, 2022 (GLOBE NEWSWIRE) — ConnectOne Bancorp, Inc. (Nasdaq: CNOB) (the “Company” or “ConnectOne”), parent company of ConnectOne Bank (the “Bank”), today reported net income available to common stockholders of $31.3 million for the fourth quarter of 2021, compared with $32.1 million for the third quarter of 2021 and $25.6 million for the fourth quarter of 2020. Diluted earnings per share were $0.79 for the fourth quarter of 2021 compared with $0.80 for the third quarter of 2021 and $0.64 for the fourth quarter of 2020. The $0.8 million decrease in net income available to common stockholders and $0.01 decrease in diluted earnings per share versus the third quarter of 2021 were primarily due to $1.7 million in preferred dividends, a $1.4 million increase in income tax expense and a $0.2 million decrease...

Continue reading

Tuesday Morning Announces Reporting Date for Second Quarter Fiscal 2022 Results

DALLAS, Jan. 27, 2022 (GLOBE NEWSWIRE) — Tuesday Morning (NASDAQ: TUEM), a leading off-price retailer of home goods and décor, today announced that the Company will hold a conference call to discuss its second quarter fiscal 2022 financial results on Thursday, February 3rd, 2022 at 8:00 am Central Time. A press release detailing the Company’s financial results will be issued before the market opens and prior to the conference call. A live webcast of the conference call will be available in the investor relations section of the Company’s website, www.tuesdaymorning.com. Investors and analysts interested in listening to the call are invited to dial 877-407-9716, or 201-493-6779 if calling internationally, approximately ten minutes prior to the start of the call. A replay of the webcast will be posted on the website for...

Continue reading

Lantronix to Report Fiscal 2022 Second Quarter Results on Feb. 10, 2022

IRVINE, Calif., Jan. 27, 2022 (GLOBE NEWSWIRE) — Lantronix Inc. (the “Company”) (NASDAQ: LTRX), a global provider of secure turnkey solutions for intelligent IT and Internet of Things (IoT), today announced it will release financial results of its fiscal 2022 second quarter, ended Dec. 31, 2021, on Feb. 10, 2022, after the close of the market. Management will host an investor conference call and audio webcast at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) on Feb. 10, 2022. To access the live conference call, investors should dial 1-844-802-2442 (US) or 1-412-317-5135 (international) and indicate that they are participating in the Lantronix fiscal 2022 second quarter call. The webcast will be available simultaneously via the investor relations section of the Company’s website at www.lantronix.com.        Investors can access...

Continue reading

Renalytix to Present at BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

NEW YORK and SALT LAKE CITY, Jan. 27, 2022 (GLOBE NEWSWIRE) — Renalytix plc (NASDAQ: RNLX) (LSE: RENX) (“Renalytix” or the “Company”) today announced the Company will be presenting at the upcoming BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference. Renalytix’s management is scheduled to participate in a fireside chat on Tuesday, February 15, 2022, at 3:30 p.m. EST. Due to the format of this virtual event the presentation will not be webcast. The company will be available for virtual 1X1 meetings with investors registered for the event. About RenalytixRenalytix (NASDAQ: RNLX) (LSE: RENX) is the global founder and leader in the new field of bioprognosis™ for kidney health. The company has engineered a new solution that successfully enables early-stage CKD progression risk assessment. The Company’s lead...

Continue reading

Tritium Rings Nasdaq Closing Bell in Honor of Listing

Bell Ringing Ceremony Took Place Yesterday at 4:00 pm ET at Nasdaq MarketSite in New York’s Times SquareTritium Ringing Nasdaq Closing BellThe Tritium team rings the Nasdaq closing bell on Australia Day to celebrate the company’s recent listing on the exchange as DCFC.BRISBANE, Australia, Jan. 27, 2022 (GLOBE NEWSWIRE) — Tritium DCFC Limited (“Tritium” or the “Company”) (Nasdaq: DCFC), a global developer and manufacturer of direct current (“DC”) fast chargers for electric vehicles (“EVs”), today announced that Company management rang the Closing Bell at Nasdaq MarketSite in New York’s Times Square yesterday afternoon at 4:00 p.m. ET, in honor of its listing on the exchange. The Company began trading on Nasdaq on January 14, 2022, following the close of its business combination...

Continue reading

BioAdaptives to Investigate Use of Lung Cleanser for Long-Term Smokers

Company to study OSCPeP device usage for active smokers and second-hand exposure Las Vegas, Nevada, Jan. 27, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — BioAdaptives, Inc. (OTCMkts:  BDPT) announced today that it is commencing preliminary investigation into the clinical utilization of its Lung Armor™ package, a combination of the Lung Cleanser™ (aka Lung Flute™) device and its PrimiLungs™ all-natural supplement, with respect to the respiratory function of long-time smokers and those exposed to second-hand smoke.  In addition, the Company will be looking for related beneficial effects that can be associated with drinking oxygenated water products made with its recently acquired patented technology. The Lung Cleanser™ is a patented, FDA-cleared, oscillating positive end pressure (OSCPEP) Class II medical device that promotes...

Continue reading

LSI Industries Reports Fiscal Second Quarter 2022 Results and Declares Quarterly Cash Dividend

CINCINNATI, Jan. 27, 2022 (GLOBE NEWSWIRE) — LSI Industries Inc. (NASDAQ: LYTS, “LSI” or the “Company”) a leading U.S. based manufacturer of indoor/outdoor lighting and display solutions, today announced results for the second quarter of fiscal year 2022. FISCAL SECOND QUARTER 2022Total net sales +45% y/y to $111.1 million, organic net sales +19% y/y Lighting sales +27% y/y; Display Solution sales +72% y/y Net Income +41% y/y to $3.1 million, or $0.11 per diluted share Adjusted net income +67% y/y to $4.2 million, or $0.15 per diluted share Adjusted EBITDA +65% y/y to $8.4 millionLSI generated significant year-over-year growth in sales and profitability in the fiscal second quarter, driven by a continued recovery in non-residential construction activity, systemic gains in targeted vertical markets, together with contributions...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.